SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/30/20 Concord Medical Svcs Holdings Ltd 20-F 12/31/19 164:22M Toppan Merrill/FA |
Document/Exhibit Description Pages Size 1: 20-F Annual Report by a Foreign Non-Canadian Issuer HTML 1.69M 2: EX-2.4 Plan of Acquisition, Reorganization, Arrangement, HTML 102K Liquidation or Succession 3: EX-8.1 Opinion of Counsel re: Tax Matters HTML 44K 6: EX-13.1 Annual or Quarterly Report to Security Holders HTML 44K 7: EX-13.2 Annual or Quarterly Report to Security Holders HTML 43K 4: EX-12.1 Statement re: Computation of Ratios HTML 49K 5: EX-12.2 Statement re: Computation of Ratios HTML 49K 8: EX-15.1 Letter re: Unaudited Interim Financial Info HTML 42K 69: R1 Document and Entity Information HTML 82K 135: R2 Consolidated Balance Sheets HTML 199K 115: R3 Consolidated Balance Sheets (Parenthetical) HTML 85K 21: R4 Consolidated Statements of Comprehensive Loss HTML 145K 74: R5 Consolidated Statements of Comprehensive Loss HTML 48K (Parenthetical) 140: R6 Consolidated Statements of Cash Flows HTML 248K 120: R7 Consolidated Statements of Shareholders' Equity HTML 112K 15: R8 Organization and Basis of Presentation HTML 349K 75: R9 Summary of Significant Accounting Policies HTML 220K 18: R10 Concentration of Risks HTML 55K 71: R11 Acquisitions and Disposals HTML 180K 136: R12 Short Term Investment HTML 47K 116: R13 Accounts Receivable HTML 97K 20: R14 Prepayments and Other Current Assets HTML 115K 73: R15 Inventories HTML 75K 138: R16 Assets Held for Sale HTML 46K 118: R17 Property, Plant and Equipment, Net HTML 86K 16: R18 Lease HTML 299K 76: R19 Goodwill HTML 71K 158: R20 Intangible Assets, Net HTML 189K 103: R21 Deposits for Non-Current Assets HTML 64K 47: R22 Long-Term Investments HTML 131K 65: R23 Other Non-Current Assets HTML 71K 160: R24 Accrued Expenses and Other Liabilities HTML 84K 105: R25 Shareholders' Equity HTML 49K 49: R26 Bank and Other Borrowings HTML 92K 67: R27 Restricted Net Assets HTML 49K 161: R28 Taxation HTML 302K 101: R29 Share-Based Awards HTML 179K 112: R30 Revenue HTML 111K 132: R31 Related Party Transactions HTML 265K 80: R32 Employee Defined Contribution Plan HTML 48K 26: R33 Commitments and Contingencies HTML 47K 110: R34 Segment Reporting HTML 168K 130: R35 Loss Per Share HTML 121K 78: R36 Fair Value Measurements HTML 165K 24: R37 Parent Company Only Condensed Financial HTML 232K Information 114: R38 Subsequent Events HTML 47K 129: R39 Summary of Significant Accounting Policies HTML 318K (Policies) 98: R40 Organization and Basis of Presentation (Tables) HTML 338K 155: R41 Summary of Significant Accounting Policies HTML 203K (Tables) 55: R42 Acquisitions and Disposals (Tables) HTML 182K 38: R43 Accounts Receivable (Tables) HTML 96K 96: R44 Prepayments and Other Current Assets (Tables) HTML 115K 153: R45 Inventories (Tables) HTML 76K 53: R46 Property, Plant and Equipment, Net (Tables) HTML 82K 36: R47 Lease (Tables) HTML 307K 100: R48 Goodwill (Tables) HTML 70K 152: R49 Intangible Assets, Net (Tables) HTML 192K 145: R50 Deposits for Non-Current Assets (Tables) HTML 63K 127: R51 Long-Term Investments (Tables) HTML 132K 27: R52 Other Non-Current Assets (Tables) HTML 71K 82: R53 Accrued Expenses and Other Liabilities (Tables) HTML 84K 146: R54 Bank and Other Borrowings (Tables) HTML 93K 128: R55 Taxation (Tables) HTML 302K 28: R56 Share-Based Awards (Tables) HTML 181K 84: R57 Revenue (Tables) HTML 110K 147: R58 Related Party Transactions (Tables) HTML 251K 126: R59 Segment Reporting (Tables) HTML 173K 41: R60 Loss Per Share (Tables) HTML 121K 56: R61 Fair Value Measurements (Tables) HTML 160K 148: R62 Parent Company Only Condensed Financial HTML 233K Information (Tables) 91: R63 Organization and Basis of Presentation (Schedule HTML 132K of Subsidiaries) (Details) 44: R64 Organization and Basis of Presentation (Schedule HTML 163K of financial information) (Details) 59: R65 Organization and Basis of Presentation (Narrative) HTML 280K (Details) 151: R66 Summary of Significant Accounting Policies HTML 57K (Schedule of Information Relating to Property, Plant and Equipment) (Details) 95: R67 Summary of Significant Accounting Policies HTML 60K (Schedule of estimated useful life for the intangible assets) (Details) 39: R68 Summary of Significant Accounting Policies HTML 48K (Summary of revenue recognized) (Details) 60: R69 Summary of Significant Accounting Policies HTML 62K (Adoption of ASU) (Details) 90: R70 Summary of Significant Accounting Policies - HTML 71K Adoption of ASU-842 (Details) 32: R71 Summary of Significant Accounting Policies HTML 101K (Narrative) (Details) 125: R72 Concentration of Risks (Narrative) (Details) HTML 57K 144: R73 Acquisitions and Disposals (Schedule of Assets and HTML 62K Liabilities of Beijing Century Friendship and Bpmc) (Details) 87: R74 Acquisitions and Disposals (Schedule of Gain HTML 48K Realized on Deemed Disposal) (Details) 29: R75 Acquisitions and Disposals (Schedule of purchase HTML 101K price as of the date of acquisition) (Details) 122: R76 Acquisitions and Disposals (Schedule of Pro forma HTML 53K Results) (Details) 141: R77 Acquisitions and Disposals (Schedule of Actual HTML 53K Results from Acquisition Date) (Details) 86: R78 Acquisitions and Disposals (Narrative) (Details) HTML 208K 34: R79 Short Term Investment (Debt Investment) (Details) HTML 50K 89: R80 Accounts Receivable (Schedule of Accounts HTML 68K Receivable) (Details) 31: R81 Accounts Receivable (Narrative) (Details) HTML 45K 124: R82 Prepayments and Other Current Assets (Schedule of HTML 75K Prepayments and Other Current Assets) (Details) 143: R83 Prepayments and Other Current Assets (Narrative) HTML 61K (Details) 88: R84 Inventories (Schedule of Inventory) (Details) HTML 59K 30: R85 Assets Held for Sale (Narrative) (Details) HTML 45K 123: R86 Property, Plant and Equipment, Net (Schedule of HTML 72K Property Plant and Equipment Net) (Details) 142: R87 Property, Plant and Equipment, Net - (Narrative) HTML 67K (Details) 85: R88 Lease (Narrative) (Details) HTML 88K 33: R89 Lease (Lease receivables) (Details) HTML 54K 42: R90 Lease (Net investment in direct financing leases) HTML 56K (Details) 57: R91 Lease (Summary of non-cancelable direct financing HTML 55K leases) (Details) 149: R92 Lease (Schedule of Prepaid Land Lease Payments) HTML 56K (Details) 93: R93 Lease (Other operating leases) (Details) HTML 50K 43: R94 Lease (Other information) (Details) HTML 53K 58: R95 Lease (Summary of future lease payments) (Details) HTML 62K 150: R96 Lease (Schedule of Estimated Annual Amortization HTML 51K Expenses) (Details) 94: R97 Lease (Lease income) (Details) HTML 57K 40: R98 Lease ( Schedule of Non-cancellable Operating HTML 56K Lease Payment) (Details) 61: R99 Goodwill (Carrying Amount) (Details) HTML 48K 162: R100 Goodwill (Narrative) (Details) HTML 49K 108: R101 Intangible Assets, Net (Schedule of Acquired HTML 101K Intangible Assets) (Details) 45: R102 Intangible Assets, Net (Schedule of Estimated HTML 55K Annual Amortization Expenses) (Details) 62: R103 Intangible Assets, Net (Narrative) (Details) HTML 52K 163: R104 Deposits for Non-Current Assets (Schedule of HTML 50K Deposits for Non-Current Assets) (Details) 109: R105 Deposits for Non-Current Assets (Schedule of HTML 59K Deposits for Non-Current Assets) (Narrative) (Details) 46: R106 Long-Term Investments (Details) HTML 51K 63: R107 Long-Term Investments (Details 1) HTML 48K 164: R108 Long-Term Investments (Schedule of Equity Method HTML 69K Investments) (Details 2) 107: R109 Long-Term Investments (Narrative) (Details) HTML 193K 119: R110 Other Non-Current Assets (Schedule of Other HTML 56K Non-Current Assets) (Details) 139: R111 Other Non-Current Assets (Narrative) (Details) HTML 46K 72: R112 Accrued Expenses and Other Liabilities (Schedule HTML 72K of Accrued Expenses and Other Liabilities) (Details) 19: R113 Shareholders' Equity (Narrative) (Details) HTML 72K 117: R114 Bank and Other Borrowings (Schedule of Bank and HTML 55K Other Borrowings) (Details) 137: R115 Bank and Other Borrowings (Schedule of Maturities HTML 62K of Long-Term and Other Debt) (Details) 70: R116 Bank and Other Borrowings (Narrative) (Details) HTML 84K 17: R117 Restricted Net Assets (Narrative) (Details) HTML 54K 121: R118 Taxation (Narrative) (Details) HTML 100K 134: R119 Taxation (Schedule of (Loss) Income from HTML 51K Continuing Operations Before Income Taxes) (Details) 68: R120 Taxation (Schedule of Income Tax Expense from HTML 53K Continuing Operations) (Details) 50: R121 Taxation (Reconciliation of Differences Between HTML 82K Statutory Tax Rate and Effective Tax Rate) (Details) 104: R122 Taxation (Reconciliation of Differences Between HTML 46K Statutory Tax Rate and Effective Tax Rate) (Parenthetical) (Details) 159: R123 Taxation (Schedule of Deferred Taxes) (Details) HTML 120K 66: R124 Taxation (Schedule of Movement of Valuation HTML 47K Allowance) (Details) 48: R125 Taxation (Reconciliation of Accrued Unrecognized HTML 58K Tax Positions) (Details) 102: R126 Share-Based Awards (Narrative) (Details) HTML 68K 157: R127 Share-Based Awards (Schedule of Assumptions Used) HTML 52K (Details) 64: R128 Share-Based Awards (Schedule of Stock Options) HTML 91K (Details) 51: R129 Share-Based Awards (Summary of Restricted Shares) HTML 112K (Details) 23: R130 Share-Based Awards (Schedule of Share-Based HTML 52K Compensation Expense) (Details) 77: R131 Revenue (Details) HTML 73K 131: R132 Related Party Transactions (Schedule of Related HTML 100K Party Transactions) (Details) 111: R133 Related Party Transactions (Schedule of Related HTML 74K Party Balances) (Details) 25: R134 Employee Defined Contribution Plan (Narrative) HTML 51K (Details) 79: R135 Commitments and Contingencies (Narrative) HTML 49K (Details) 133: R136 Segment Reporting (Narrative) (Details) HTML 50K 113: R137 Segment Reporting (Schedule of Segment HTML 67K Information) (Details) 22: R138 Segment Reporting (Schdeule of Net Revenue by HTML 51K Country based upon Sales Location that Predominately represents Customer Location) (Details) 81: R139 Segment Reporting (Schdeule of Total Long-Lived HTML 50K Assets excluding Financial Instruments, Intangible Assets and Deferred Tax Assets by Country) (Details) 35: R140 Loss Per Share (Schedule of Basic and Diluted HTML 69K Income Per Share) (Details) 52: R141 Fair Value Measurements (Schedule of Fair Value HTML 68K Measurements for Each Class of Assets on Nonrecurring Basis) (Details) 154: R142 Fair Value Measurements (Narrative) (Details) HTML 51K 97: R143 Parent Company Only Condensed Financial HTML 121K Information (Condensed balance Sheets) (Details) 37: R144 Parent Company Only Condensed Financial HTML 67K Information (Condensed balance Sheets) (Parenthetical) (Details) 54: R145 Parent Company Only Condensed Financial HTML 90K Information (Condensed statements of comprehensive loss) (Details) 156: R146 Parent Company Only Condensed Financial HTML 64K Information (Condensed statements of cash flows) (Details) 99: R147 Subsequent Events (Narrative) (Details) HTML 57K 83: XML IDEA XML File -- Filing Summary XML 327K 106: EXCEL IDEA Workbook of Financial Reports XLSX 210K 9: EX-101.INS XBRL Instance -- ccm-20191231 XML 7.89M 11: EX-101.CAL XBRL Calculations -- ccm-20191231_cal XML 369K 12: EX-101.DEF XBRL Definitions -- ccm-20191231_def XML 1.28M 13: EX-101.LAB XBRL Labels -- ccm-20191231_lab XML 2.38M 14: EX-101.PRE XBRL Presentations -- ccm-20191231_pre XML 2.13M 10: EX-101.SCH XBRL Schema -- ccm-20191231 XSD 410K 92: ZIP XBRL Zipped Folder -- 0001104659-20-054484-xbrl Zip 441K
Exhibit 13.2
Certification by the Chief Financial Officer
Pursuant to Section 906 of the Sarbanes Oxley Act of 2002
In connection with the Annual Report on Form 20-F of Concord Medical Services Holdings Limited (the “Company”) for the year ended December 31, 2019 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Yaw Kong Yap, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002, that to my knowledge:
1. | The Report containing the financial statements fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: April 30, 2020 | ||
By: | /s/ Yaw Kong Yap | |
Name: | Yaw Kong Yap | |
Title: | Chief Financial Officer | |
C:
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/19/24 Concord Medical Svcs Holdings Ltd 20-F 12/31/23 166:21M Toppan Merrill/FA 4/19/23 Concord Medical Svcs Holdings Ltd 20-F 12/31/22 170:22M Toppan Merrill/FA2 4/29/22 Concord Medical Svcs Holdings Ltd 20-F 12/31/21 170:23M Toppan Merrill/FA2 10/15/21 Concord Medical Svcs Holdings Ltd 20-F 12/31/20 166:22M Toppan Merrill/FA |